Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and Neoplasms, Squamous Cell

gemcitabine has been researched along with Neoplasms, Squamous Cell in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahlberg, SE; Hoang, T; Johnson, DH; Schiller, JH1
Fujita, S; Fukuhara, A; Hatachi, Y; Irisa, K; Kim, YH; Masago, K; Mio, T; Mishima, M; Nagai, H; Sakamori, Y; Togashi, Y1
Harrington, C; James, M; Wynne, C1
Cariati, A1
Carlson, D; Fury, MG; Haque, S; Pfister, D; Shen, R; Stambuk, H1
Li, B; Li, J; Zhong, M1
Benasso, M; Corvò, R; Pallestrini, E; Ponzanelli, A; Ricci, I; Rosso, R; Sanguineti, G; Santelli, A; Vitale, V1
Bielawska, A; Bielawski, J; Cobanoglu, B; Day, TA; Hannun, YA; Koybasi, S; Meyer, M; Obeid, LM; Ogretmen, B; Ponnusamy, S; Rossi, MJ; Senkal, CE; Sinha, D; Sundararaj, K; Szulc, Z1

Trials

4 trial(s) available for gemcitabine and Neoplasms, Squamous Cell

ArticleYear
Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594.
    Lung cancer (Amsterdam, Netherlands), 2013, Volume: 81, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Squamous Cell; Paclitaxel; Retrospective Studies; Taxoids; Treatment Outcome

2013
Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer.
    Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Hematologic Diseases; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms, Squamous Cell; Organoplatinum Compounds; Survival Analysis; Treatment Outcome

2011
A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer.
    Cancer, 2011, Feb-15, Volume: 117, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Glutamates; Guanine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Squamous Cell; Pemetrexed; Recurrence; Squamous Cell Carcinoma of Head and Neck

2011
Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:4

    Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Fever; Gemcitabine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Squamous Cell; Neutropenia; Survival Analysis; Survival Rate; Thrombocytopenia; Treatment Outcome

2004

Other Studies

4 other study(ies) available for gemcitabine and Neoplasms, Squamous Cell

ArticleYear
Radiation myelopathy after 36 Gy in 12 fractions palliative chest radiotherapy for squamous cell cancer of the lung: case report and review of published studies.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2010, Volume: 22, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Dose Fractionation, Radiation; Fatal Outcome; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Squamous Cell; Palliative Care; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Spinal Cord; Spinal Cord Diseases; Thorax; Tomography, X-Ray Computed

2010
Cisplatin plus gemcitabine for biliary tract cancer.
    The New England journal of medicine, 2010, Jul-08, Volume: 363, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Deoxycytidine; Gemcitabine; Glutamates; Guanine; Humans; Neoplasms, Squamous Cell; Pemetrexed

2010
Acute transverse myelopathy probably related to intravenous gemcitabine plus cisplatin.
    The Annals of pharmacotherapy, 2011, Volume: 45, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Myelitis, Transverse; Neoplasms, Squamous Cell

2011
Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 317, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cations; Cell Line, Tumor; Cell Proliferation; Ceramides; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Head and Neck Neoplasms; Humans; Inactivation, Metabolic; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Mice, SCID; Neoplasms, Squamous Cell; Pyridinium Compounds; Tissue Distribution; Xenograft Model Antitumor Assays

2006